These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

241 related articles for article (PubMed ID: 18239298)

  • 1. Optimization of metformin HCl 500 mg sustained release matrix tablets using Artificial Neural Network (ANN) based on Multilayer Perceptrons (MLP) model.
    Mandal U; Gowda V; Ghosh A; Bose A; Bhaumik U; Chatterjee B; Pal TK
    Chem Pharm Bull (Tokyo); 2008 Feb; 56(2):150-5. PubMed ID: 18239298
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Application of design of experiments and multilayer perceptrons neural network in the optimization of diclofenac sodium extended release tablets with Carbopol 71G.
    Ivić B; Ibrić S; Cvetković N; Petrović A; Trajković S; Djurić Z
    Chem Pharm Bull (Tokyo); 2010 Jul; 58(7):947-9. PubMed ID: 20606343
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Formulation and in vitro studies of a fixed-dose combination of a bilayer matrix tablet containing metformin HCl as sustained release and glipizide as immediate release.
    Mandal U; Pal TK
    Drug Dev Ind Pharm; 2008 Mar; 34(3):305-13. PubMed ID: 18363146
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Artificial neural networks in the modeling and optimization of aspirin extended release tablets with Eudragit L 100 as matrix substance.
    Ibrić S; Jovanović M; Djurić Z; Parojcić J; Petrović SD; Solomun L; Stupar B
    AAPS PharmSciTech; 2003; 4(1):E9. PubMed ID: 12916918
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Application of an artificial neural network in the design of sustained-release dosage forms].
    Wei XH; Wu JJ; Liang WQ
    Yao Xue Xue Bao; 2001 Sep; 36(9):690-4. PubMed ID: 12580110
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Formulation and optimization of sustained release matrix tablet of metformin HCl 500 mg using response surface methodology.
    Mandal U; Gowda V; Ghosh A; Selvan S; Solomon S; Pal TK
    Yakugaku Zasshi; 2007 Aug; 127(8):1281-90. PubMed ID: 17666882
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Optimization of matrix tablets controlled drug release using Elman dynamic neural networks and decision trees.
    Petrović J; Ibrić S; Betz G; Đurić Z
    Int J Pharm; 2012 May; 428(1-2):57-67. PubMed ID: 22402474
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Artificial neural networks in the optimization of a nimodipine controlled release tablet formulation.
    Barmpalexis P; Kanaze FI; Kachrimanis K; Georgarakis E
    Eur J Pharm Biopharm; 2010 Feb; 74(2):316-23. PubMed ID: 19815063
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Design porosity osmotic tablet for delivering low and pH-dependent soluble drug using an artificial neural network.
    Patel A; Mehta T; Patel M; Patel K; Patel N
    Curr Drug Deliv; 2012 Sep; 9(5):459-67. PubMed ID: 22746271
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Formulation optimization technique based on artificial neural network in salbutamol sulfate osmotic pump tablets.
    Wu T; Pan W; Chen J; Zhang R
    Drug Dev Ind Pharm; 2000 Feb; 26(2):211-5. PubMed ID: 10697759
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Systematic development of pH-independent controlled release tablets of carvedilol using central composite design and artificial neural networks.
    Aktas E; Eroglu H; Kockan U; Oner L
    Drug Dev Ind Pharm; 2013 Aug; 39(8):1207-16. PubMed ID: 22804226
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Integration of artificial neural network and physiologically based biopharmaceutic models in the development of sustained-release formulations.
    Severino Martins F; Borges L; Oliveira do Couto R; Schaller S; de Freitas O
    Biopharm Drug Dispos; 2023 Aug; 44(4):335-343. PubMed ID: 37649136
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Development and optimization of a novel sustained-release dextran tablet formulation for propranolol hydrochloride.
    Gil EC; Colarte AI; Bataille B; Pedraz JL; Rodríguez F; Heinämäki J
    Int J Pharm; 2006 Jul; 317(1):32-9. PubMed ID: 16584856
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of four artificial neural network software programs used to predict the in vitro dissolution of controlled-release tablets.
    Chen Y; Jiao T; McCall TW; Baichwal AR; Meyer MC
    Pharm Dev Technol; 2002; 7(3):373-9. PubMed ID: 12229268
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Optimization and evaluation of time-dependent tablets comprising an immediate and sustained release profile using artificial neural network.
    Xie H; Gan Y; Ma S; Gan L; Chen Q
    Drug Dev Ind Pharm; 2008 Apr; 34(4):363-72. PubMed ID: 18401778
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Towards functional characterization of excipients for oral solid dosage forms using UV-vis imaging. Liberation, release and dissolution.
    Li Z; Sun Y; Bar-Shalom D; Mu H; Larsen SW; Jensen H; Østergaard J
    J Pharm Biomed Anal; 2021 Feb; 194():113789. PubMed ID: 33298380
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Solid dispersions in the development of a nimodipine floating tablet formulation and optimization by artificial neural networks and genetic programming.
    Barmpalexis P; Kachrimanis K; Georgarakis E
    Eur J Pharm Biopharm; 2011 Jan; 77(1):122-31. PubMed ID: 20934511
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mathematical Model-Based Accelerated Development of Extended-release Metformin Hydrochloride Tablet Formulation.
    Chen W; Desai D; Good D; Crison J; Timmins P; Paruchuri S; Wang J; Ha K
    AAPS PharmSciTech; 2016 Aug; 17(4):1007-13. PubMed ID: 26729531
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of dibutyrylchitin as new excipient for sustained drug release.
    Casettari L; Cespi M; Castagnino E
    Drug Dev Ind Pharm; 2012 Aug; 38(8):979-84. PubMed ID: 22124336
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Study of controlled-release floating tablets of dipyridamole using the dry-coated method.
    Chen K; Wen H; Yang F; Yu Y; Gai X; Wang H; Li P; Pan W; Yang X
    Drug Dev Ind Pharm; 2018 Jan; 44(1):116-124. PubMed ID: 28956647
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.